DDIT4 regulates mesenchymal stem cell fate by mediating between HIF1α and mTOR signalling

Borzo Gharibi1, Mandeep Ghuman1, Francis J Hughes1

  • 1Division of Tissue Engineering and Biophotonics, Dental Institute, King's College London, Tower Wing, Guy's Hospital, London, SE1 9RT. UK.

Scientific Reports
|November 24, 2016
PubMed

Insights

DNA Damage Inducible Transcript 4 (DDIT4) links HIF1α and mTOR signaling to control adult stem cell fate. This discovery reveals how DDIT4 regulates stem cell self-renewal and differentiation.

Area of Science:

  • Stem cell biology
  • Molecular signaling pathways
  • Adult stem cell homeostasis

Background:

  • Stem cell fate is determined by external cues and internal pathways.
  • Understanding the molecular mechanisms governing stem cell self-renewal and differentiation is crucial.

Purpose of the Study:

  • To investigate the role of DNA Damage Inducible Transcript 4 (DDIT4) in adult stem cell fate.
  • To elucidate the connection between DDIT4, HIF1α, and mTOR signaling in stem cell regulation.

Main Methods:

  • Global gene expression analysis of mesenchymal stem cells (MSCs).
  • Live RNA cell sorting and single-clone derivation.
  • Loss-of-function and gain-of-function experiments.

Main Results:

  • DDIT4 expression correlates with MSC differentiation potential.
  • DDIT4 regulates mTOR signaling, pluripotency gene expression, and differentiation.
  • DDIT4 acts downstream of HIF1α in regulating stem cell fate.

Conclusions:

  • DDIT4 serves as a critical link between HIF1α and mTOR signaling pathways.
  • DDIT4 plays a key role in coordinating stem cell self-renewal and differentiation.
  • Findings offer insights into adult stem cell homeostasis regulation.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K